72 related articles for article (PubMed ID: 7560834)
1. Evolving trends in pancreatic cancer therapeutic development.
Bijou I; Wang J
Ann Pancreat Cancer; 2019 Oct; 2():. PubMed ID: 33089149
[TBL] [Abstract][Full Text] [Related]
2. An Investigation on the Results of Cytopathologic Tests of Pancreatobiliary System Performed in the Pathology Department in Iran.
Moradi A; Sadeghi A; Asadzadeh Aghdaei H; Mollasharifi T; Ahadi M; Jamali E; Taghavi A; Foroozandeh Shahraki N; Moradi A
Iran J Pathol; 2021; 16(3):256-265. PubMed ID: 34306121
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of brush cytology alone and in combination with tumor markers in pancreaticobiliary strictures.
Kuzu UB; Ödemiş B; Turhan N; Parlak E; Dişibeyaz S; Suna N; Öztaş E; Akpınar MY; Aksoy A; Torun S; Yıldız H; Kayaçetin E
Gastroenterol Res Pract; 2015; 2015():580254. PubMed ID: 25883643
[TBL] [Abstract][Full Text] [Related]
4. Experimental animal models of pancreatic carcinogenesis and metastasis.
Wei D; Xiong HQ; Abbruzzese JL; Xie K
Int J Gastrointest Cancer; 2003; 33(1):43-60. PubMed ID: 12909737
[TBL] [Abstract][Full Text] [Related]
5. A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy.
Wang B; Shi Q; Abbruzzese JL; Xiong Q; Le X; Xie K
Int J Pancreatol; 2001; 29(1):37-46. PubMed ID: 11558631
[TBL] [Abstract][Full Text] [Related]
6. Mouse models of metastatic pancreatic adenocarcinoma.
Xie K; Wang B; Shi Q; Abbruzzese JL; Xiong Q; Le X
Int J Pancreatol; 2001; 29(1):25-35. PubMed ID: 11558630
[TBL] [Abstract][Full Text] [Related]
7. Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases.
Stewart CJ; Mills PR; Carter R; O'Donohue J; Fullarton G; Imrie CW; Murray WR
J Clin Pathol; 2001 Jun; 54(6):449-55. PubMed ID: 11376018
[TBL] [Abstract][Full Text] [Related]
8. Evolving strategies for the treatment of adenocarcinoma of the pancreas. A review.
Ettinghausen SE; Schwartzentruber DJ; Sindelar WF
J Clin Gastroenterol; 1995 Jul; 21(1):48-60. PubMed ID: 7560834
[TBL] [Abstract][Full Text] [Related]
9. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
[TBL] [Abstract][Full Text] [Related]
10. Advances in the surgical management of pancreatic cancer.
Spanknebel K; Conlon KC
Cancer J; 2001; 7(4):312-23. PubMed ID: 11561607
[TBL] [Abstract][Full Text] [Related]
11. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
12. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
[TBL] [Abstract][Full Text] [Related]
13. Multimodality management of localized pancreatic cancer.
Wayne JD; Wolff RA; Pisters PW; Evans DB
Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
